Portal › Forums › Lung/Thoracic Cancer › General Lung/Thoracic Cancer › ASCO 2013 Video: Are molecular markers just for NSCLC?
This topic contains 0 replies, has 1 voice, and was last updated by JimC Forum Moderator 4 years, 11 months ago.
In the newest ASCO 2013 video, Dr. Mary Pinder of Moffitt Cancer Center reviews the CUSTOM trial, in which the study of molecular markers was expanded to patients with small cell lung cancer and thymic carcinomas.
You can view the video here: http://cancergrace.org/lung/2013/06/28/custom-trial-sclc-thymic-carcinoma/
We welcome your questions and comments here.
Jul 2008 Wife Liz (51/never smoker) Dx Stage IV NSCLC EGFR exon 19
4 cycles Carbo/alimta, 65% shrinkage
Mar 2010 progression, added Alimta, stable
Sep 2010 multiple brain mets, WBR
Oct 2010 large pericardial effusion, tamponade
Jan 2011 progression, start abraxane
Jun 2011-New liver, brain mets, add Tarceva
Oct 2011-Dx Leptomeningeal carcinomatosis; pulsed Tarceva
At rest Nov 4 2011
Since then: http://cancergrace.org/blog/jim-and-lisa
You must be logged in to reply to this topic.
Subscribe toGRACE Notes (Free Newsletter)
Mission | Disclaimer